<abstract xmlns="http://www.w3.org/1999/xhtml"><p> Giant cell tumors of the bone are tumors whose malignant character has long been debated. Lung metastases have been reported in some cases. They usually represent osteolytic, locally aggressive bone tumors for which surgery is the standard of care. Denosumab is the most effective systemic treatment in these cases, but both the timing and the duration are a matter of debate. The aim of this short review was to describe the most important trials that treated patients with this drug and to discuss both advantages and long-term toxicity. It can be concluded from the presented data that the choice of adding denosumab in the treatment sequence of giant cell tumor of the bone has to be taken in a personalized manner for each patient.</p></abstract>

Giant cell tumors of the bone are tumors whose malignant character has long been debated. Lung metastases have been reported in some cases. They usually represent osteolytic, locally aggressive bone tumors for which surgery is the standard of care. Denosumab is the most effective systemic treatment in these cases, but both the timing and the duration are a matter of debate. The aim of this short review was to describe the most important trials that treated patients with this drug and to discuss both advantages and long-term toxicity. It can be concluded from the presented data that the choice of adding denosumab in the treatment sequence of giant cell tumor of the bone has to be taken in a personalized manner for each patient.

Denosumab efficacy in giant cell tumors of the bone - short review

Romanian Journal of Orthopaedic Surgery and Traumatology

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

{"article-title":"Denosumab efficacy in giant cell tumors of the bone - short review"}

Giant cell tumors of the bone are tumors whose malignant character has long been debated. Lung metastases have been reported in some cases. They usually...

Denosumab efficacy in giant cell tumors of the bone - short review

Publié en ligne: 18 janv. 2019

Pages: 109 - 111

DOI: https://doi.org/10.2478/rojost-2018-0088

Mots clés
denosumab, giant cell tumor of the bone

© 2019 Cornelia Nitipir, et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Denosumab efficacy in giant cell tumors of the bone - short review

Publié en ligne: 18 janv. 2019

Pages: 109 - 111

DOI: https://doi.org/10.2478/rojost-2018-0088

Mots clésdenosumab, giant cell tumor of the bone

© 2019 Cornelia Nitipir, et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Mots clés
denosumab, giant cell tumor of the bone